It suggests that the effects of NAFLD on the anti-inflammatory functionality of apoB-depleted plasma cannot be entirely explained by the obesity and involvement of additional NAFLD-specific mechanisms seem likely. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.